written on 11.04.2014

EU takes up testosterone drug review on cardio worries


The FDA has been reviewing testosterone drugs since January of this year on concerns over their cardiovascular safety. Now, its across-the-pond counterpart is following suit, embarking on its own review following worrisome study data.

Latest Reports